Study Finds That Hydroxychloroquine Helped Patients Survive Coronavirus, Cutting Death Rates In Half
A surprising new study found that the controversial antimalarial drug hydroxychloroquine helped patients better survive in the hospital.
A team at Henry Ford Health System in Southeast Michigan said Thursday its study of 2,541 hospitalized patients found that those given hydroxychloroquine were much less likely to die.
Dr. Marcus Zervos, division head of infectious disease for Henry Ford Health System, said 26% of those not given hydroxychloroquine died, compared to 13% of those who got the drug. The team looked back at everyone treated in the hospital system since the first patient in March.